Biotechnology Stock Doubled This: Fund Bets 1.2M Shares
A large fund snapped up 1.2 million Vir Biotechnology shares as the stock doubled this past year. Here’s how to read ...
Understand the key factors for determining when to sell stocks and buy bonds to optimize your investment strategy.
28,656 articlesA large fund snapped up 1.2 million Vir Biotechnology shares as the stock doubled this past year. Here’s how to read ...
Analysts publish a broad slate of Wednesday notes, highlighting opportunities across metals, energy, consumer staples...
Bitcoin tumbled toward $20,000 as a wave of selling and shifting flows rattled investors. A six-factor framework expl...
A global pop icon revealed a major political shift, and the financial ripple effects are real. Learn practical money ...
A U.S. regulator just opened a door for an ambitious ocean mining player. This article breaks down what the NOAA appr...
The co-author behind a viral AI disruption post says he was shorting the stocks he described, adding another layer to...
XLRE has surged about 11% year-to-date, but analysts warn that rising yields could pressure capital gains while AFFO-...
U.S. stocks drift as a slate of fresh analyst calls prompts traders to reassess positions in consumer, tech and indus...
Could Palantir move higher over the next year? This guide breaks down three realistic scenarios, key catalysts, and p...
This week brought a sharp move in Poet Technologies shares as a dilutive financing announcement rattled investors. Le...
When lululemon shares dropped after the company cut its annual forecast, it sent a clear message about the market's g...
Palantir stock slipped from its peak, triggering questions about value, risk, and timing for late 2026. This guide br...